Man Group
VKTX icon

Man Group’s Viking Therapeutics VKTX Stock Holding History

Man Group’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
312,171
+72,908
+30% +$2.36M 0.02% 691
2026
Q1 		$7.79M Sell
239,263
-21,038
-8% -$676K 0.01% 926
2025
Q4 		$9.16M Buy
260,301
+250,762
+2,629% +$8.89M 0.02% 838
2025
Q3 		$251K Sell
9,539
-10,940
-53% -$326K ﹤0.01% 2060
2025
Q2 		$543K Sell
20,479
-6,572
-24% -$173K ﹤0.01% 1805
2025
Q1 		$653K Sell
27,051
-421,681
-94% -$13.3M ﹤0.01% 1700
2024
Q4 		$18.1M Buy
448,732
+435,813
+3,373% +$24.9M 0.05% 466
2024
Q3 		$818K Sell
12,919
-13,820
-52% -$811K ﹤0.01% 1546
2024
Q2 		$1.42M Buy
+26,739
New +$1.75M ﹤0.01% 1444
2023
Q1 		– Sell
-14,953
Closed -$154K – 1807
2022
Q4 		$141K Sell
14,953
-167,730
-92% -$749K ﹤0.01% 1843
2022
Q3 		$497K Buy
+182,683
New +$598K ﹤0.01% 1522
2022
Q2 		– Sell
-12,400
Closed -$30.7K – 1508
2022
Q1 		$37K Buy
+12,400
New +$44.5K ﹤0.01% 2134
2018
Q4 		– Sell
-12,087
Closed -$211K – 2126
2018
Q3 		$211K Buy
+12,087
New +$144K ﹤0.01% 2014

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Man Group's VKTX Position: Q2 2026 in Review

Man Group increased its Viking Therapeutics (VKTX) stake by 30% in Q2 2026, buying an estimated $2.36M and bringing the position to 312,171 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #691.

Man Group first reported a position in VKTX in Q3 2018 and has held it in 13 quarters since. The position peaked at $18.1M in Q4 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Man Group held 312,171 shares of Viking Therapeutics worth $12.2M as of Q2 2026.
  • Man Group bought 72,908 Viking Therapeutics shares in Q2 2026, an estimated $2.36M.
  • Viking Therapeutics made up 0.02% of Man Group's portfolio in Q2 2026, its #691 holding.
  • Man Group first reported a position in Viking Therapeutics in Q3 2018 and has held it in 13 quarters since.
  • Man Group's Viking Therapeutics position peaked at $18.1M in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.